Dr. Kathy Jean Krook, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 18 W Main St, Suite A, Chilton, WI 53014 Phone: 920-849-9518 |
Dr. Michael Chistopher Popelars, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1110 E Chestnut St, Chilton, WI 53014 Phone: 920-849-9667 |
Dr. Mariah L Murphy, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 15 E Main St, Chilton, WI 53014 Phone: 920-849-9341 Fax: 920-849-9342 |
Dr. Michael Stanley Baus, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 15 E Main St, Po 71, Chilton, WI 53014 Phone: 920-849-9341 |
Dr. Christopher H Berkers, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 451 E Brooklyn St Ste 1, Chilton, WI 53014 Phone: 920-849-9667 |
Dr. Lara L Devine, RN, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 15 E Main St, Chilton, WI 53014 Phone: 920-849-9341 Fax: 920-849-9342 |
News Archive
Innovative software tools allowed the scientists to construct accurate "maps" of gene networks for about 400 different human cell and tissue types, ranging from immune cells to brain tissues, whereas previous studies were limited to just one or few tissues.
Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of a class consisting of all persons or entities who purchased the securities of Hansen Medical, Inc. between May 1, 2008 and October 18, 2009, inclusive (the "Class Period").
A new paper, available on the medRxiv* preprint server, indicates the adaptation undergone by the SARS-CoV-2 molecular genome and the pH1N1 influenza pandemic strain during the first year of their spread, separately. Using statistical and phylogenetic skills, the researchers present a picture of the emergence, rates of change, and of growth, of these two viruses as time passes.
Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, for the development and commercialization of lead immuno-oncology drug candidate APG101 in China, Macao, and Hong Kong.
In a new study published online in spring 2021 and in the July issue of the journal Contraception, University of Chicago Medicine investigators and colleagues interviewed primary care providers in Illinois about their interest in providing medication abortion care and found that lifting FDA restrictions on mifepristone to allow pharmacy dispensing could normalize medication abortion, facilitate its use in primary care facilities, and address disparities in reproductive health access.
› Verified 7 days ago